Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
London School of Hygiene & Tropical Medicine · KU Leuven · +2 more institutions
Abstract
A novel SARS-CoV-2 variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in November 2020 and is rapidly spreading towards fixation. Using a variety of statistical and dynamic modelling approaches, we estimate that this variant has a 43–90% (range of 95% credible intervals 38–130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine roll-out, COVID-19 hospitalisations and deaths across England in 2021 will exceed those in 2020. Concerningly, VOC…
Citation impact
- FWCI
- —
- Percentile
- —
- References
- 62
Authors
24- NGNicholas G. DaviesCorresponding
London School of Hygiene & Tropical Medicine
- SASam Abbott
London School of Hygiene & Tropical Medicine
- RCRosanna C. Barnard
London School of Hygiene & Tropical Medicine
- CJChristopher Jarvis
London School of Hygiene & Tropical Medicine
- AJAdam J. Kucharski
London School of Hygiene & Tropical Medicine
Topics & keywords
- Transmissibility (structural dynamics)
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
- Lineage (genetic)
- Transmission (telecommunications)
- 2019-20 coronavirus outbreak
- Geography
- New england
- Good health and well-being
Funding
- BABill and Melinda Gates FoundationAward: OPP1184344
- UOUniversity of Bern
- WTWellcome TrustAwards: 206250, 210758/Z/18/Z, 206250/Z/17/Z, Z/17/Z, 221303/Z/20/Z, 221303, 210758
- URUK Research and InnovationAwards: ES/P010873/1, ES/P010873, ES/P010873/
- UBUniversitätsspital Basel
- NINational Institute for Health Research Health Protection Research UnitAwards: NIHR200908, NIHR200929
- NINational Institute for Health and Care ResearchAwards: NIHR200929, NIHR200908
- RCResearch Councils UKAward: ES/P010873/1
- UOUniversity of Warwick
- ECEuropean CommissionAward: 101003688
- PHPublic Health England
- ETEidgenössische Technische Hochschule Zürich
- HUHôpitaux Universitaires de Genève
- FCForeign, Commonwealth and Development OfficeAward: 221303/Z/20/Z
- MRMedical Research CouncilAwards: 206250/Z/17/Z, NIHR200908, MC_PC_19065
- EAEconomic and Social Research CouncilAward: ES/P010873/1
- SSStatens Serum Institut
- REResearch England